Zobrazeno 1 - 6
of 6
pro vyhledávání: '"35"'
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 12:434-439
Objective Morbid obesity (body mass index S 35 kg/m2)usually confers a higher perioperative risk in cardiac surgery. Robotic cardiac surgery may have many advantages for these high-risk patients. Methods We retrospectively reviewed patients undergoin
Autor:
Masaki Funamoto, Edward Soltese, Scott C. Silvestry, George Batsides, Elias Zias, David A. D'Alessandro, Masahiro Ono, Anthony Lemaire, Danny Ramzy, Mark E. Anderson
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 16:365-372
Objective To report the initial clinical experience with the Impella 5.5® with SmartAssist®, a temporary left ventricular assist device that provides up to 6.2 L/min forward flow, with recent FDA approval for up to 14 days. Methods From October 201
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 14:209-217
Objective To assess early and late clinical outcomes in patients who underwent aortic valve repair surgery for aortic valve insufficiency, and to investigate predictors for recurrence. Methods Of 151 consecutive patients who underwent aortic valve re
Autor:
Richard B. Schuessler, Spencer J. Melby, Vivek Hansalia, Farah N. Musharbash, Matthew R. Schill, Jeremy E. Leidenfrost, Ralph J. Damiano
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 13:261-266
Objective Septal myectomy remains the criterion standard for the treatment of patients with hypertrophic obstructive cardiomyopathy refractory to medical therapy. There have been few reports of minimally invasive approaches. This study compared a min
Autor:
Danny Ramzy, Joseph M. Massaro, Mark B. Anderson, Anson Cheung, Edward G. Soltesz, George Batsides
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 13:254-260
Objective The aim of the study was to comprehensively summarize the survival outcomes and complications of Impella 5.0 (Abiomed Inc, Danvers, MA USA) use in patients with cardiogenic shock (CS). Methods We performed a literature review for relevant s
Autor:
Daniel Ocazionez, Matthew D. Terwelp, Richard W. Smalling, Yelin Zhao, Tom C. Nguyen, Vinod H. Thourani, Anthony L. Estrera, Catalin Loghin, Justin Q. Pham, Prakash Balan, Joseph Lamelas
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 12:33-40
Objective Low ejection fraction (EF < 40%) portends adverse outcomes in patients undergoing valvular heart surgery. The role of traditional median sternotomy aortic valve replacement (SAVR) compared with minimally invasive aortic valve replacement (M